1
|
Stewart AF: Clinical practice.
Hypercalcemia associated with cancer. N Engl J Med. 352:373–379.
2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Hiller N, Sonnenblick M and Hershko C:
Paraneoplastic hypercalcemia in endometrial carcinoma. Oncology.
46:45–48. 1989. View Article : Google Scholar : PubMed/NCBI
|
3
|
Buller R, Taylor K, Burg AC, Berman ML and
DiSaia PJ: Paraneoplastic hypercalcemia associated with
adenosquamous carcinoma of the endometrium. Gynecol Oncol.
40:95–98. 1991. View Article : Google Scholar : PubMed/NCBI
|
4
|
Sachmechi I, Kalra J, Molho L and Chawla
K: Paraneoplastic hypercalcemia associated with uterine papillary
serous carcinoma. Gynecol Oncol. 58:378–82. 1995. View Article : Google Scholar : PubMed/NCBI
|
5
|
Kinugasa Y, Morishige K, Kamiura S,
Tsukamoto Y and Saji F: Parathyroid hormone-related
protein-secreting uterine endometrioid adenocarcinoma. Jpn J Clin
Oncol. 36:113–115. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ashour AA, Verschraegen CF, Kudelka AP and
Kavanagh JJ: Paraneoplastic syndromes of gynecologic neoplasms. J
Clin Oncol. 15:1272–1282. 1997.PubMed/NCBI
|
7
|
Savvari P, Peitsidis P, Alevizaki M,
Dimopoulos MA, Antsaklis A and Papadimitriou CA: Paraneoplastic
humorally mediated hypercalcemia induced by parathyroid
hormone-related protein in gynecologic malignancies: a systematic
review. Onkologie. 32:517–23. 2009. View Article : Google Scholar
|
8
|
Broadus AE, Mangin M, Ikeda K, Insogna KL,
Weir EC, Burtis WJ, et al: Humoral hypercalcemia of cancer.
Identification of a novel parathyroid hormone-like peptide. N Engl
J Med. 319:556–563. 1988.PubMed/NCBI
|
9
|
Hoshi S, Morimoto T, Saito H, Ichizuka K,
Matsuoka R, Yanaihara A, et al: PTHrP and PTH/PTHrP receptor
expressions in human endometrium. Endocr J. 48:219–225. 2001.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Mok LL, Nickols GA, Thompson JC and Cooper
CW: Parathyroid hormone as a smooth muscle relaxant. Endocr Rev.
10:420–436. 1989. View Article : Google Scholar : PubMed/NCBI
|
11
|
Williams ED, Leaver DD, Danks JA, Moseley
JM and Martin TJ: Effect of parathyroid hormone-related protein
(PTHrP) on the contractility of the myometrium and localization of
PTHrP in the uterus of pregnant rats. J Reprod Fertil. 102:209–214.
1994. View Article : Google Scholar : PubMed/NCBI
|
12
|
Heffner LJ, Kumari M and Benoit LA:
Secretion of the vasoactive peptides, endothelin, and parathyroid
hormone-related peptide, by decidual explants from pregnancies
complicated by intrauterine growth restriction. J Soc Gynecol
Investig. 6:273–277. 1999. View Article : Google Scholar
|
13
|
Schilling T, Pecherstorfer M, Blind E,
Leidig G, Ziegler R and Raue F: Parathyroid hormone-related protein
(PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in
hypercalcemia of malignancy. J Clin Endocrinol Metab. 76:801–803.
1993.PubMed/NCBI
|
14
|
Syed MA, Horwitz MJ, Tedesco MB,
Garcia-Ocana A, Wisniewski SR and Stewart AF: Parathyroid
hormone-related protein-(1–36) stimulates renal tubular calcium
reabsorption in normal human volunteers: implications for the
pathogenesis of humoral hypercalcemia of malignancy. J Clin
Endocrinol Metab. 86:1525–1531. 2001.
|
15
|
Jaishuen A, Jimenez C, Sirisabya N, Li Y,
Zheng H, Hu W, et al: Poor survival outcome with moderate and
severe hypercalcemia in gynecologic malignancy patients. Int J
Gynecol Cancer. 19:178–185. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Richey DS and Welch BJ: Concurrent primary
hyperparathyroidism and humoral hypercalcemia of malignancy in a
patient with clear cell endometrial cancer. South Med J.
101:1266–1268. 2008. View Article : Google Scholar : PubMed/NCBI
|